Erratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44-S45].

Janni, WolfgangChan, ArleneNusch, ArndAlba, EmilioBachelot, ThomasGil-Gil, MiguelKattan, JosephBourgeois, HuguesEl Karak, FadiSutradhar, SantoshMiller, MichelleChandiwana, DavidConte, Pierfranco2023-01-252023-01-252018http://hdl.handle.net/10668/12708enErratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44-S45].research article30005916open access10.1016/j.breast.2018.04.0071532-3080http://www.thebreastonline.com/article/S0960977618300705/pdf